Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study.
Identifieur interne : 001590 ( Main/Corpus ); précédent : 001589; suivant : 001591Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study.
Auteurs : T S Dabakuyo ; F. Guillemin ; T. Conroy ; M. Velten ; D. Jolly ; M. Mercier ; S. Causeret ; J. Cuisenier ; O. Graesslin ; M. Gauthier ; F. BonnetainSource :
- Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [ 1573-2649 ] ; 2013.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Breast Neoplasms (drug therapy), Breast Neoplasms (psychology), Fatigue (MeSH), Female (MeSH), France (MeSH), Health Status (MeSH), Hospitalization (MeSH), Humans (MeSH), Middle Aged (MeSH), Postoperative Period (MeSH), Prospective Studies (MeSH), Quality of Life (MeSH), Retrospective Studies (MeSH), Self Care (MeSH), Self Report (MeSH), Statistics, Nonparametric (MeSH), Surveys and Questionnaires (MeSH), Visual Analog Scale (MeSH).
- MESH :
- geographic : France.
- drug therapy : Breast Neoplasms.
- psychology : Breast Neoplasms.
- Adult, Aged, Fatigue, Female, Health Status, Hospitalization, Humans, Middle Aged, Postoperative Period, Prospective Studies, Quality of Life, Retrospective Studies, Self Care, Self Report, Statistics, Nonparametric, Surveys and Questionnaires, Visual Analog Scale.
Abstract
PURPOSE
To characterize response shift effects in patients with breast cancer (BC).
METHODS
The QLQ-C30, BR23, and EurQOL-EQ-5D were assessed at baseline and at the end of the first hospitalization. We used the then-test approach to characterize changes in internal standards by calculating the mean difference between the then-test (retrospective measure) and pre-test baseline QoL assessments. The Ideal Scale Approach was also used to assess changes in standards by comparing health and QoL expectancies between baseline and the end of the first hospitalization. Successive Comparison Approach was used to assess changes in values through the longitudinal assessment of the relative importance of EuroQOL dimensions.
RESULTS
The results of this study showed that recalibration RS effects occurred early after the first hospitalization for 6/15 dimensions of QLQ-C30 (emotional, cognitive, fatigue, insomnia, appetite loss, diarrhea) and 2/8 of BR-23 (future perspective, systemic therapy side effects). Moreover, health and QoL expectancies changed between the baseline and the end of the first hospitalization, and changes in values were seen for the self-care and usual activities dimensions of the EuroQOL-EQ-5D.
CONCLUSIONS
The occurrence of RS early after the first hospitalization suggests that it needs to be taken into account to interpret QoL changes in BC.
DOI: 10.1007/s11136-012-0135-5
PubMed: 22383104
Links to Exploration step
pubmed:22383104Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study.</title>
<author><name sortKey="Dabakuyo, T S" sort="Dabakuyo, T S" uniqKey="Dabakuyo T" first="T S" last="Dabakuyo">T S Dabakuyo</name>
<affiliation><nlm:affiliation>Biostatistics and Epidemiology Unit, Centre Georges François Leclerc, 1 rue Professeur Marion, 21000, Dijon, France. sdabakuyo@cgfl.fr</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Guillemin, F" sort="Guillemin, F" uniqKey="Guillemin F" first="F" last="Guillemin">F. Guillemin</name>
</author>
<author><name sortKey="Conroy, T" sort="Conroy, T" uniqKey="Conroy T" first="T" last="Conroy">T. Conroy</name>
</author>
<author><name sortKey="Velten, M" sort="Velten, M" uniqKey="Velten M" first="M" last="Velten">M. Velten</name>
</author>
<author><name sortKey="Jolly, D" sort="Jolly, D" uniqKey="Jolly D" first="D" last="Jolly">D. Jolly</name>
</author>
<author><name sortKey="Mercier, M" sort="Mercier, M" uniqKey="Mercier M" first="M" last="Mercier">M. Mercier</name>
</author>
<author><name sortKey="Causeret, S" sort="Causeret, S" uniqKey="Causeret S" first="S" last="Causeret">S. Causeret</name>
</author>
<author><name sortKey="Cuisenier, J" sort="Cuisenier, J" uniqKey="Cuisenier J" first="J" last="Cuisenier">J. Cuisenier</name>
</author>
<author><name sortKey="Graesslin, O" sort="Graesslin, O" uniqKey="Graesslin O" first="O" last="Graesslin">O. Graesslin</name>
</author>
<author><name sortKey="Gauthier, M" sort="Gauthier, M" uniqKey="Gauthier M" first="M" last="Gauthier">M. Gauthier</name>
</author>
<author><name sortKey="Bonnetain, F" sort="Bonnetain, F" uniqKey="Bonnetain F" first="F" last="Bonnetain">F. Bonnetain</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:22383104</idno>
<idno type="pmid">22383104</idno>
<idno type="doi">10.1007/s11136-012-0135-5</idno>
<idno type="wicri:Area/Main/Corpus">001590</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001590</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study.</title>
<author><name sortKey="Dabakuyo, T S" sort="Dabakuyo, T S" uniqKey="Dabakuyo T" first="T S" last="Dabakuyo">T S Dabakuyo</name>
<affiliation><nlm:affiliation>Biostatistics and Epidemiology Unit, Centre Georges François Leclerc, 1 rue Professeur Marion, 21000, Dijon, France. sdabakuyo@cgfl.fr</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Guillemin, F" sort="Guillemin, F" uniqKey="Guillemin F" first="F" last="Guillemin">F. Guillemin</name>
</author>
<author><name sortKey="Conroy, T" sort="Conroy, T" uniqKey="Conroy T" first="T" last="Conroy">T. Conroy</name>
</author>
<author><name sortKey="Velten, M" sort="Velten, M" uniqKey="Velten M" first="M" last="Velten">M. Velten</name>
</author>
<author><name sortKey="Jolly, D" sort="Jolly, D" uniqKey="Jolly D" first="D" last="Jolly">D. Jolly</name>
</author>
<author><name sortKey="Mercier, M" sort="Mercier, M" uniqKey="Mercier M" first="M" last="Mercier">M. Mercier</name>
</author>
<author><name sortKey="Causeret, S" sort="Causeret, S" uniqKey="Causeret S" first="S" last="Causeret">S. Causeret</name>
</author>
<author><name sortKey="Cuisenier, J" sort="Cuisenier, J" uniqKey="Cuisenier J" first="J" last="Cuisenier">J. Cuisenier</name>
</author>
<author><name sortKey="Graesslin, O" sort="Graesslin, O" uniqKey="Graesslin O" first="O" last="Graesslin">O. Graesslin</name>
</author>
<author><name sortKey="Gauthier, M" sort="Gauthier, M" uniqKey="Gauthier M" first="M" last="Gauthier">M. Gauthier</name>
</author>
<author><name sortKey="Bonnetain, F" sort="Bonnetain, F" uniqKey="Bonnetain F" first="F" last="Bonnetain">F. Bonnetain</name>
</author>
</analytic>
<series><title level="j">Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation</title>
<idno type="eISSN">1573-2649</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Breast Neoplasms (drug therapy)</term>
<term>Breast Neoplasms (psychology)</term>
<term>Fatigue (MeSH)</term>
<term>Female (MeSH)</term>
<term>France (MeSH)</term>
<term>Health Status (MeSH)</term>
<term>Hospitalization (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Postoperative Period (MeSH)</term>
<term>Prospective Studies (MeSH)</term>
<term>Quality of Life (MeSH)</term>
<term>Retrospective Studies (MeSH)</term>
<term>Self Care (MeSH)</term>
<term>Self Report (MeSH)</term>
<term>Statistics, Nonparametric (MeSH)</term>
<term>Surveys and Questionnaires (MeSH)</term>
<term>Visual Analog Scale (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>France</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Fatigue</term>
<term>Female</term>
<term>Health Status</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Postoperative Period</term>
<term>Prospective Studies</term>
<term>Quality of Life</term>
<term>Retrospective Studies</term>
<term>Self Care</term>
<term>Self Report</term>
<term>Statistics, Nonparametric</term>
<term>Surveys and Questionnaires</term>
<term>Visual Analog Scale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>PURPOSE</b>
</p>
<p>To characterize response shift effects in patients with breast cancer (BC).</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>The QLQ-C30, BR23, and EurQOL-EQ-5D were assessed at baseline and at the end of the first hospitalization. We used the then-test approach to characterize changes in internal standards by calculating the mean difference between the then-test (retrospective measure) and pre-test baseline QoL assessments. The Ideal Scale Approach was also used to assess changes in standards by comparing health and QoL expectancies between baseline and the end of the first hospitalization. Successive Comparison Approach was used to assess changes in values through the longitudinal assessment of the relative importance of EuroQOL dimensions.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>The results of this study showed that recalibration RS effects occurred early after the first hospitalization for 6/15 dimensions of QLQ-C30 (emotional, cognitive, fatigue, insomnia, appetite loss, diarrhea) and 2/8 of BR-23 (future perspective, systemic therapy side effects). Moreover, health and QoL expectancies changed between the baseline and the end of the first hospitalization, and changes in values were seen for the self-care and usual activities dimensions of the EuroQOL-EQ-5D.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>The occurrence of RS early after the first hospitalization suggests that it needs to be taken into account to interpret QoL changes in BC.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22383104</PMID>
<DateCompleted><Year>2014</Year>
<Month>03</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2649</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>22</Volume>
<Issue>1</Issue>
<PubDate><Year>2013</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation</Title>
<ISOAbbreviation>Qual Life Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study.</ArticleTitle>
<Pagination><MedlinePgn>1-11</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11136-012-0135-5</ELocationID>
<Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To characterize response shift effects in patients with breast cancer (BC).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The QLQ-C30, BR23, and EurQOL-EQ-5D were assessed at baseline and at the end of the first hospitalization. We used the then-test approach to characterize changes in internal standards by calculating the mean difference between the then-test (retrospective measure) and pre-test baseline QoL assessments. The Ideal Scale Approach was also used to assess changes in standards by comparing health and QoL expectancies between baseline and the end of the first hospitalization. Successive Comparison Approach was used to assess changes in values through the longitudinal assessment of the relative importance of EuroQOL dimensions.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The results of this study showed that recalibration RS effects occurred early after the first hospitalization for 6/15 dimensions of QLQ-C30 (emotional, cognitive, fatigue, insomnia, appetite loss, diarrhea) and 2/8 of BR-23 (future perspective, systemic therapy side effects). Moreover, health and QoL expectancies changed between the baseline and the end of the first hospitalization, and changes in values were seen for the self-care and usual activities dimensions of the EuroQOL-EQ-5D.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The occurrence of RS early after the first hospitalization suggests that it needs to be taken into account to interpret QoL changes in BC.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dabakuyo</LastName>
<ForeName>T S</ForeName>
<Initials>TS</Initials>
<AffiliationInfo><Affiliation>Biostatistics and Epidemiology Unit, Centre Georges François Leclerc, 1 rue Professeur Marion, 21000, Dijon, France. sdabakuyo@cgfl.fr</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Guillemin</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Conroy</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Velten</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jolly</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mercier</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Causeret</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cuisenier</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Graesslin</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gauthier</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bonnetain</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2012</Year>
<Month>03</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Qual Life Res</MedlineTA>
<NlmUniqueID>9210257</NlmUniqueID>
<ISSNLinking>0962-9343</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006304" MajorTopicYN="Y">Health Status</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012648" MajorTopicYN="N">Self Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011795" MajorTopicYN="Y">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064232" MajorTopicYN="N">Visual Analog Scale</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2012</Year>
<Month>02</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>3</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>3</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>3</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">22383104</ArticleId>
<ArticleId IdType="doi">10.1007/s11136-012-0135-5</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Eur J Cancer. 2009 Apr;45(6):931-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19171476</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pain Symptom Manage. 2009 Mar;37(3):341-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18757176</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Qual Life Outcomes. 2005 Mar 30;3:21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15799784</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Qual Life Res. 2010 May;19(4):455-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20084465</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Epidemiol. 2003 May;56(5):395-407</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12812812</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Oncol. 1996 Oct;14(10):2756-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8874337</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Qual Life Outcomes. 2010 Jul 10;8:65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20618978</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Qual Life Res. 2006 Nov;15(9):1533-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17031503</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Qual Life Res. 2010 May;19(4):483-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20151208</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Fundam Clin Pharmacol. 2004 Jun;18(3):351-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15147288</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Soc Sci Med. 1999 Jun;48(11):1577-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10400258</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Oncol. 1999;38(6):709-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10522761</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Oncol. 2009 Aug;20(8):1352-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19468032</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Qual Life Res. 2010 May;19(4):465-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20112000</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Epidemiol. 2004 Jun;57(6):561-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15246124</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Natl Cancer Inst. 1993 Mar 3;85(5):365-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8433390</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Oncol. 2008 Feb;19(2):276-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17962200</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Soc Sci Med. 1999 Jun;48(11):1517-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10400254</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Policy. 1990 Dec;16(3):199-208</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10109801</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Epidemiol. 2009 Nov;62(11):1173-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19595570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Qual Life Res. 2000;9(6):603-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11236851</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Oncol. 1998 Jan;16(1):139-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9440735</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Bone Joint Surg Am. 2006 Dec;88(12):2590-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17142408</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Qual Life Res. 2005 Apr;14(3):611-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16022056</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Soc Sci Med. 1999 Jun;48(11):1531-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10400255</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Qual Life Outcomes. 2004 Mar 15;2:14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15023229</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Restor Neurol Neurosci. 2002;20(3-4):93-101</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12454358</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Soc Sci Med. 1999 Jun;48(11):1507-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10400253</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Qual Life Outcomes. 2005 Sep 07;3:55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16146573</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Surg Oncol. 2010 Jun;36(6):520-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20452169</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Qual Life Res. 2005 Apr;14(3):599-609</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16022055</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001590 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001590 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= AutomedicationFrancoV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:22383104 |texte= Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:22383104" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a AutomedicationFrancoV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |